Keywords: ipsen, fares, well, bourse, listing, french, drugmaker

Ipsen fares well since Bourse listing

Article | 27 March 2006

French drugmaker Ipsen, which specializes in the development of oncology, endocrinology drugs and treatments for neuromuscular disorders, has seen its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Ipsen

Roche

Go to company listing

Related Drugs

Abobotulinumtoxin A Injection

Dysport

Botox

Botulinum Toxin Type A

Go to drug listing